A father picks up his young child and give them a kiss.

Financial Story

Investors

Path to grow: Reset. Strengthen. Strive.

Investors > Overview
Latest News
Jan 13, 2025
Endo Launches New Peyronie's Disease Campaign: I Got Somebody

Disease awareness campaign encourages men to overcome their embarrassment and openly discuss Peyronie's disease (PD), taking charge of their health. Campaign empowers men to connect with trusted...

Dec 20, 2024
Endo USA, Inc. Issues Voluntary, Nationwide Recall of Adrenalin® Chloride Solution (EPINEPHrine nasal solution, USP) Due to the Potential for Administration Errors

MALVERN, PA, December 20, 2024 – Endo, Inc (OTCQX: NDOI) (“Endo”), announced today that one of its operating subsidiaries, Endo USA, Inc., is voluntarily recalling all lots within expiry of...

Dec 16, 2024
Endo Announces Publication of Peyronie's Disease Self-Assessment Screening App Article in Peer-Reviewed Translational Andrology and Urology

Endo, Inc. (OTCQX: NDOI) announced today the publication of the Peyronie's disease (PD) self-assessment screening app by the peer-reviewed journal Translational Andrology and Urology. Read the...

View All Press Releases

Our Board

Governance

Endo’s board of directors oversees and advises our leaders to protect the long-term interests of the company and our shareholders. The experienced and independent board members are committed to building sustainable success.

Directors Committees Policies & Guidelines

Overview

This is body copy - it will be turned off in site mgr